• No results found

Chemotherapy regimens

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis

... 63 regimens considered, 7 chemotherapy regimens that may achieve better overall survival than gemcitabine monotherapy for locally advanced and metastatic pancreatic cancer patients, with NSC-631570 ...

14

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

... (3) chemotherapy: first-line therapy; (4) disease stage: stage III or IV; (5) patient population: hospital-based patient; (6) subjects: at least one measurable lesion in patients with metastatic/ advanced breast ...

11

Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan

Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan

... cancer chemotherapy should be considered in addition to effectiveness and adverse events in the selection of treatment regimens [5, ...treatment regimens on the basis of only effectiveness and ...

9

Original Article Cost-effective use of aprepitant in multiple-day chemotherapy regimens

Original Article Cost-effective use of aprepitant in multiple-day chemotherapy regimens

... Abstract: Background: Aprepitant is a highly effective but expensive antiemetic drug. Repeated treatment with apre- pitant is required to control emesis in multiple-day chemotherapy. In the present study, ...

11

Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens

Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens

... 30 patients in Arm II (P = 1). Furthermore, the incidence of grade III–IV nausea and vomiting were higher in the FEC arm (6/30) versus the FEC-D arm (4/30) (P = 0.49). Hema- tological malignancy was not monitored in ...

5

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer

... Between October 2010 and December 2014, the Affiliated Cancer Hospital of Guangxi Medical University (Guangxi, China) enrolled 139 female patients whose age ranged from 27 to 70 years, with a median age of 47 years. All ...

9

Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date

<p>Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date</p>

... combination regimens have also been unable to overcome doxo- rubicin in terms of overall ...of chemotherapy regimens in the salvage setting was unable to demonstrate a benefit in progression-free or ...

16

Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

... Objectives: Transferability of economic evaluations to low- and middle- income countries through adaptation of models is important; however, several methodological and practical challenges remain. Given its significant ...

11

Effects of chemotherapy upon fertility amongst women of reproductive age, using AMH as a marker of ovarian reserve

Effects of chemotherapy upon fertility amongst women of reproductive age, using AMH as a marker of ovarian reserve

... different chemotherapy regimens and 12 who received total body ...with chemotherapy alone, AMH levels as well as AFC were lower compared to a group of healthy volunteers with regular menstrual cycles ...

311

Efficacy of pemetrexed-based regimens in advanced non&ndash;small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

Efficacy of pemetrexed-based regimens in advanced non&ndash;small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

... Pemetrexed-based chemotherapy regimens (pem regimens) are the standard first-line treatment option in patients with non-squamous non–small cell lung cancer ...pem regimens were ...pem ...

9

Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

... Objectives: Transferability of economic evaluations to low- and middle- income countries through adaptation of models is important; however, several methodological and practical challenges remain. Given its significant ...

10

GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study.

GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study.

... new chemotherapy regimens and combining radiotherapy and chemotherapy has significantly evolved in recent years and failure in treatment is seen only in 10 to 20% of ...

5

Original Article Clinicopathologic features of ovarian carcinosarcoma: a report of 17 cases

Original Article Clinicopathologic features of ovarian carcinosarcoma: a report of 17 cases

... OCS a rare kind of ovarian cancer, which shows high invasive and poor prognosis. Clinical guidelines of treatment management for OCS patients haven’t been reached. A large amount of retrospective studies indicated that ...

7

Review of mifamurtide in the treatment of patients with osteosarcoma

Review of mifamurtide in the treatment of patients with osteosarcoma

... standard chemotherapy regimens as an adjuvant in the treatment of patients with high-grade osteo- sarcoma truly results in an unequivocally proven benefit is still ongoing, and as outlined above, the ...

8

Oral Health Status in Patients Undergoing Chemotherapy for Lung Cancer

Oral Health Status in Patients Undergoing Chemotherapy for Lung Cancer

... Abstract Purpose: The main purpose of this study was to assess the oral health status of patients receiving two different chemotherapy regimens (cisplatin/etoposide vs cisplatin/vinorelbine) for non small ...

5

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

... of chemotherapy was a significant prognostic factor in the multivariate analysis for PFS with a significantly worse outcome in patients receiving pazopanib in the third- or fourth-line settings versus the first- ...

11

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma

... Comprehensive Geriatric Assessment (CGA) is defined as a multidimensional, interdisciplinary diagnostic process focusing on determining an older person’s co-morbidities, psychosocial, and functional capabilities to ...

6

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study

... therapy regimens commonly used in the female setting are also effective in mMBC patients after endocrine ...palliative chemotherapy including progres- sion after multiple endocrine treatments, unacceptable ...

5

2017_Buhlinger.pdf

2017_Buhlinger.pdf

... This retrospective, single cohort study took place at the University of North Carolina Medical Center (UNCMC). The UNCMC electronic medical records were queried to identify our patient cohort who had received treatment ...

11

Prevention of multi drug resistant,extensively drug resistant and total drug resistant tuberculosis

Prevention of multi drug resistant,extensively drug resistant and total drug resistant tuberculosis

... atleast 4 new drugs, the patient has not taken previously or to which the bacilli is considered to be sensitive are given.There are 5 groups of Anti Tuberculosis drugs. Include drugs from group 1to5 in hierarchical ...

5

Show all 4484 documents...

Related subjects